The Europe Cardiac Marker Testing Market should witness market growth of 8.1% CAGR during the forecast period (2022-2028).
Cardiac biomarkers assist medical professionals in determining whether a heart attack (myocardial infarction), angina, heart failure, or another issue is to blame for a patient's symptoms. Increases in cardiac enzymes might potentially be a sign of myocardial ischemia or acute coronary syndrome (ACS). These conditions are treated in various ways. Making sure one receive the right care depends on a precise diagnosis.
Cardiac markers include enzymes, hormones, and proteins. They are utilized in patients for diagnosis and risk stratification in relation to chest discomfort and suspected acute coronary syndrome. They measure blood pressure and heart rate. The cardiology industry predicted to develop at the highest rate is the cardiac marker testing market, which offers excellent specificity and can aid in the detection of disorders in the early stages of presentation such as troponins.
The countries in this region have some of the best healthcare facilities in the world. According to the International Trade Administration, Germany has a very developed and powerful market for medical supplies. Carl Zeiss, Siemens, and Dragerwerk are among the companies with a long history of manufacturing high-quality medical equipment, with an emphasis on diagnostic imaging, precise medical tools, and optical technology.
The Germany market dominated the Europe Cardiac Marker Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $530.4 million by 2028. The UK market is estimated to grow a CAGR of 7.2% during (2022-2028). Additionally, The France market would experience a CAGR of 8.9% during (2022-2028).
Based on Disease, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Atherosclerosis, Acute Coronary Syndrome and Ischemia. Based on End-user, the market is segmented into Laboratory Testing Facilities, Point-of-Care Testing Facilities and Academic Institutions. Based on Product, the market is segmented into Reagents & Kits and Instruments. Based on Biomarker Type, the market is segmented into Troponin I & T, Creatine kinase-MB(CK-MB), Natriuretic peptide (Bnp Or Nt-Probnp), Myoglobin, High-sensitivity C-reactive protein(hs-CRP) and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG (Siemens AG), PerkinElmer, Inc., BioMérieux S.A., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., and DiaSorin S.p.A.
Cardiac biomarkers assist medical professionals in determining whether a heart attack (myocardial infarction), angina, heart failure, or another issue is to blame for a patient's symptoms. Increases in cardiac enzymes might potentially be a sign of myocardial ischemia or acute coronary syndrome (ACS). These conditions are treated in various ways. Making sure one receive the right care depends on a precise diagnosis.
Cardiac markers include enzymes, hormones, and proteins. They are utilized in patients for diagnosis and risk stratification in relation to chest discomfort and suspected acute coronary syndrome. They measure blood pressure and heart rate. The cardiology industry predicted to develop at the highest rate is the cardiac marker testing market, which offers excellent specificity and can aid in the detection of disorders in the early stages of presentation such as troponins.
The countries in this region have some of the best healthcare facilities in the world. According to the International Trade Administration, Germany has a very developed and powerful market for medical supplies. Carl Zeiss, Siemens, and Dragerwerk are among the companies with a long history of manufacturing high-quality medical equipment, with an emphasis on diagnostic imaging, precise medical tools, and optical technology.
The Germany market dominated the Europe Cardiac Marker Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $530.4 million by 2028. The UK market is estimated to grow a CAGR of 7.2% during (2022-2028). Additionally, The France market would experience a CAGR of 8.9% during (2022-2028).
Based on Disease, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Atherosclerosis, Acute Coronary Syndrome and Ischemia. Based on End-user, the market is segmented into Laboratory Testing Facilities, Point-of-Care Testing Facilities and Academic Institutions. Based on Product, the market is segmented into Reagents & Kits and Instruments. Based on Biomarker Type, the market is segmented into Troponin I & T, Creatine kinase-MB(CK-MB), Natriuretic peptide (Bnp Or Nt-Probnp), Myoglobin, High-sensitivity C-reactive protein(hs-CRP) and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG (Siemens AG), PerkinElmer, Inc., BioMérieux S.A., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., and DiaSorin S.p.A.
Scope of the Study
By Disease
- Myocardial Infarction
- Congestive Heart Failure
- Atherosclerosis
- Acute Coronary Syndrome
- Ischemia
By End-user
- Laboratory Testing Facilities
- Point-of-Care Testing Facilities
- Academic Institutions
By Product
- Reagents & Kits
- Instruments
By Biomarker Type
- Troponin I & T
- Creatine kinase-MB(CK-MB)
- Natriuretic peptide (Bnp Or Nt-Probnp)
- Myoglobin
- High-sensitivity C-reactive protein(hs-CRP)
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Danaher Corporation
- Siemens Healthineers AG (Siemens AG)
- PerkinElmer, Inc.
- BioMérieux S.A.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- DiaSorin S.p.A.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. Europe Cardiac Marker Testing Market by Disease
Chapter 5. Europe Cardiac Marker Testing Market by End-user
Chapter 6. Europe Cardiac Marker Testing Market by Product
Chapter 7. Europe Cardiac Marker Testing Market by Biomarker Type
Chapter 8. Europe Cardiac Marker Testing Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Danaher Corporation
- Siemens Healthineers AG (Siemens AG)
- PerkinElmer, Inc.
- BioMérieux S.A.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- DiaSorin S.p.A.
Methodology
LOADING...
